Shao Wei-Li 4

What Happened

• Shao Wei‑Li, President of Omada Health (OMDA), was granted 264,705 restricted stock units (RSUs) on March 5, 2026. The grant price reported is $0.00 per share, so there was no cash outlay at grant and the reported acquisition value is $0.
• These RSUs convert to one share of common stock per RSU upon vesting; the award is an equity compensation grant rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-03-05; Filing date (Form 4): 2026-03-13 (filed 8 days after the transaction — appears late relative to the usual 2‑business‑day Form 4 deadline).
• Amount granted: 264,705 RSUs; price per share: $0.00; reported value at grant: $0.
• Shares owned after the transaction: Not disclosed in the provided filing.
• Footnote: The RSUs vest 1/16th each quarterly anniversary starting March 1, 2026 (the Vesting Commencement Date), so 100% vests on the fourth anniversary (i.e., over 16 quarters).
• No indication in the provided data of tax‑withholding, 10b5‑1 plan, or sale upon vesting.

Context

• This is an award/grant (code A) — typical executive compensation to align management with long‑term shareholder value. Grants are not immediate purchases and do not necessarily signal an immediate market view.
• Vesting spreads the economic benefit over four years; shares are only received as the RSUs vest. The late filing may be a reporting compliance issue but does not change the nature of the grant.